The basic endocrine defect in Klinefelter syndrome appears to be gonadal. The relative roles of the testicular structure and function observed at puberty and elevated gonadotropin secretion is not presently understood. We found that during childhood, serum gonadotropin levels are normal even following GnRH stimulation. By midpuberty, Klinefelter subjects are hypergonadotropic, even though their basal T levels are not markedly reduced and T secretion can be increased further either by the administration of hCG or infusion of sufficient GnRH to raise endogenous LH even further. It would appear that high circulating gonadotropin levels may exacerbate the primary testicular lesion and cause the progressive hyalinization and fibrosis. Eventually, testicular damage or a local effect of intratesticular estrogen leads to diminished T reserve. It remains to be seen to what extent early aggressive T therapy might influence the course of this adolescent endocrine dysfunction.
Studies of nutrition in infancy have sought to establish minimum requirements of essential amino acids using diets in which there were deficient or minimal intakes of specific amino acids, or by extrapolating values from the diets of infants growing normally (2, 5, 7, 8, 10-12, 14, 16, 17). It has generally been assumed that growth is limited by the amount of available essential amino acids. Nitrogen balance is also helpful but less so in that infants stop growing at reduced levels of amino acid intake at which nitrogen balance is still positive. Each of these measures is more useful in determining satisfactory levels at which normal growth will proceed than in determining actual minimal requirements. Furthermore, the values employed in nutritional counseling represent the upper level of the ranges obtained in studies on amino acid requirements (5, 8, 14) . This is appropriate in the management of normal individuals, but it may provide toxic levels of precursor in an infant with an inherited disorder of metabolism. Initial experience led us to conclude that accepted values for requirements were generous (21, 22) . For these reasons we began a systematic study of the requirements of amino acids in infants and children with inborn errors of metabolism (20). We and others have hypothesized that infants with inborn errors of amino acid metabolism provide a unique opportunity to determine minimal requirements of essential amino acids (26, 29) . Since these disorders represent defects in metabolism, metabolites accumulate whenever intake exceeds requirements. Using the measurement of the accumulating metabolite to keep amino acid intake equal to the rate of turnover at the level of anabolic requirements permits a very precise definition of minimal requirements, as assessed by growth in weight and nitrogen balance. The addition of the accumulating metabolite or metabolites permits a determination df a floor as well as the ceiling provided by rates of growth and nitrogen balance to the ranges obtained in any individual infant. In addition at minimal levels of amino acid intake, the contribution of supplemental nonessential nitrogen can be readily assessed.
Patients with disorders of propionate metabolism are specifically intolerant of branched-chain amino acids. Because of the site of the enzyme defects they cannot properly metabolize isoleucine, threonine, methionine, and valine. Leucine does not follow this catabolic pathway, but patients with propionic acidemia are highly intolerant of leucine (3). Branched chain amino acids are thought to be preferentially catabolized in muscle where they provide a major nitrogen source for the biosynthesis of alanine from pyruvate in the alanine-glucose cycle (6, 28). Alanine so formed from carbohydrate in muscle is transported to the liver where it is converted first to pyruvate and then to glucose. It was reasoned that the provision of alanine in amounts additional to those found in dietary whole protein might spare the catabolism of essential amino acids in muscle, permitting optimal growth on lower levels of potentially toxic precursors and lower levels of accumulation of toxic intermediates. The design of the experiment was to determine the level of protein intake just below that at which growth occurred, and then to assess the effects of supplemental alanine. It was found that the addition of alanine permitted the resumption of growth at rates equivalent to those of higher levels of protein intake. That this was not simply an effect of nonessential nitrogen was indicated by the failure of glycine or glutamic acid to substitute for alanine.
PATIENTS AND METHODS E.A. was a 7-month-old Libyan female with propionic acidemia. There was close consanguinity in that the father's father and the mother's grandfather were brothers. A previous male sibling had died of the disease. C.H. was a 7-month-old female with methylmalonic acidemia. A previous sibling had died of the disease. Studies were carried out in the General Clinical Research Center at the UCSD Medical Center. E.A. was 8 months old at the completion of the baseline nutritional studies, and was 11 months old at the completion of the entire study. C.H. rvas 8 months old at the completion of the baseline nutritional studies, and was 14 months old at the completion of the entire study.
Both infants were maintained on a specially formulated diet in which the caloric intake was provided by mixtures of Enfamil (Mead Johnson and Co., Evansville, IN) as the protein source, and Mead Johnson Product 80056, to provide additional carbohydrate and fat. Polycose (Ross Laboratories, Columbus, OH) glucose polymer and/or corn oil were used to supplement calories as needed. Additional vitamins, trace elements, and iron were provided at maintenance requiremets. Caloric distribution was approximately 40% as carbohydrate, 55% as fat, and 3-5% protein. The caloric density of each formula was approximately 1 kcal/ml.
In studies on E.A. two basic formats were employed (Table I ). In the first she received 100 kcal/kg, and a fixed dose of protein was employed, 5.0 g in the initial baseline period and 4.0 g thereafter. In the second (cycles E through J) the caloric intake was reduced to 80 kcallkg and, after an initial cycle at 5.0 g, a protein intake of 0.75 g/kg was prescribed. After the baseline period of 3 wk of a diet containing 100 kcallkg day and 0.75 g protein/kg/day (Table I) , the infant underwent a series of 7-day studies. In each cycle an initial 4 days was considered to provide a steady state following dietary change, after which stool and urine for nitrogen balance were collected during the last 3 days of each cycle. L-Alanine, glycine and L-glutamic acids were added as the crystalline amino acids (Ajinomoto Co., Inc., Tokyo, Japan). The formula was fed by continuous nasal gastric infusion and any lost through emesis was replaced. Formulations were calculated on the basis of the weight at the beginning of each cycle. Intake was calculated based on manufacturer's product information and standard dietary tables. The effect of alanine was observed in the course of these studies. Studies were then undertaken in C.H. (Table 2 ) in which the intake of protein was systematically varied between 0.8 and 0.55 g/kg.
Patients were weighed daily in the nude. The rate of change in weight was calculated from initial to final day and divided by the number of days in the cycle. The pattern growth in weight was required to be continuous throughout a cycle in order to exclude shifts of fluid that might occur in the first days of a cycle. Furthermore, cycles were required to be at least 7 days in duration, and we did not prolong a period of study in which no weight gain was occumng. However, some of the successful cycles, especially those in which alanine was added, were continued for weeks, during which time there was continued maintenance of rates of growth. Nitrogen excretion was determined on three 24-h urine and 72-h stool collections by a modified Kjeldahl method (N. M. Alexander, unpublished data), using the Berthelot reaction, and the results were averaged.
RESULTS
During the BA (Table l) , E.A. was in positive nitrogen balance and had an average weight gain of 23 g/day. The 5.0 g of protein represented 0.75 g/kg. The addition of 1.0 g of alanine (177 mg/ kg) in cycle A induced further positive nitrogen balance but did not alter the rate of growth in weight. When the intake of protein was reduced to 4.0 g (cycles B-D) it amounted to 0.58 g/kg (cycle B). Weight gain was reduced to 15 g/day and nitrogen balance decreased. The addition of alanine (cycle C) restored the rate of weight gain to 23 g/day, the baseline level, and increased nitrogen balance. Provision of an equal amount of nitrogen as glycine (cycle D) did not permit a satisfactory gain in weight.
In the second series of experiments (cycles E and F), the caloric intake was decreased to 80 kcal/kg/day, while the intake of nitrogen as protein was increased to 5.0 g/day. In the absence of the alanine (cycle F) there was loss of weight at this level of caloric and protein intake (0.68 g/kg), while supplementation with alanine (cycle E) resulted in a gain of 13 g/day in weight. In all subsequent cycles protein intake was provided in g/kg per cycle. In cycle G the provision of alanine supplement at 80 kcal/ kg and 0.67 g/kg of protein led to a weight gain of 30 g/day. Substitution of glutamic acid for alanine (cycle H) failed to promote weight gain despite positive nitrogen balance.
Reduction of the caloric intake to 70 kcallkg (cycle I) abolished weight gain at 0.67 g/kg of protein despite alanine supplementation. At this level caloric intake appeared to be limiting. Increasing the caloric intake to 75 kcallkg (cycle J) restored weight gain. Comparison of cycle F with BA in which 5 g of protein were provided indicated again the influence of caloric intake, for quite satisfactory gain in weight was seen at 100 kcal/ kg and there was weight loss at 80 kcal/kg. Of course the patient's weight had increased during this time so the protein intake had decreased from 0.75 to 0.68 g/kg. However, in cycle B a level of protein intake of 0.58 g/kg was associated with satisfactory gain in weight at 100 kcal/kg. The experiments shown in Table 1 represented a substantial passage of time in which the patient's requirements for protein and calories were decreasing. Thus in the last two cycles, nitrogen retention was excellent, but she did not grow when receiving less than 75 kcal/kg.
In experiments with C.H. (Table 2 ), experience gained with E.A. permitted the systematic alteration of the separate variables demonstrating the ability of alanine to substitute for protein at limiting levels of protein intake. As protein was decreased from 0.8 g/kg in the BA to 0.6 g/kg in cycle A there was no decrease in the rate of weight gain when 1.0 g/kg of alanine was provided. Removal of the alanine in cycle B led to reduced rate of weight gain. These experiments were camed out with a generous supply of calories at 100 kcal/kg. Reduction of caloric intake to 80 kcal/ kg in cycle C at 0.6 g/kg of protein in the presence of alanine led to the same rate of gain as in the BA. Lowering of the caloric intake to 75 kcallkg and of protein intake to 0.55 g/gk in cycle D resulted in cessation of weight gain again. This established the lower limits of caloric and protein intake. The addition of alanine restored weight gain to the baseline level or above (cycle E), as did the supply of additional protein in cycle F to 0.6 g/kg. Nitrogen balance was very little different on all of these regimens. Nevertheless, it was always greater in the presence of alanine. It was concluded that at this age at an intake of 75 kcal/kg, 0.6 g/ kg of whole protein was a limiting level below which growth would not occur. However, in the presence of added alanine, growth proceeded at 0.55 g/kg, a level below this inflection point. In interpreting these data it is important to comment that experiments like this take time and by the time the patient had reached cycles D, E, and F she was older than in cycles A, B, and C, and her requirements for protein and calories had decreased. Thus she grew much better while receiving 0.6 g/kg of protein and only 75 kcallkg in cycle F than on 0.6 g/kg and 100 kcallkg in cycle B. In this series of studies we believe it is appropriate to compare cycles BA, A, and C and separately to compare cycles D, E, and F.
Data on the excretion of organic acid metabolites are shown in Table 3 . All of these concentrations represent excellent levels of control. In C.H. the excretion of methylmalonic acid was a little less in cycle A when she received alanine than in cycle BA, the baseline. In E.A. the excretions of methylcitric acid and 3-hydroxypropionic acid were very low during the baseline period. The other values are more representative of a very good level of control in this patient. It is specifically of interest that the levels were not higher during the period of glycine administration in cycle D than in the period of alanine administration. Concentrations of amino acids in the plasma are shown in Table 4 . Neither patient was appreciably hyperglycinemic during this study. Also the concentration of glycine in the plasma during cycle D when glycine was fed to E.A. was no greater than in the baseline period.
DISCUSSION
These observations indicate that alanine has a protein-sparing anabolic effect that permits growth at levels of essential amino acids below those usually required for growth. This was clearly shown in studies on C.H. In addition in experiments with E.A., there was no growth when less than 0.7 g/kg was supplied on a diet containing 80 kcal/kg. However, the provision of additional alanine demonstrated an excellent rate of weight gain at this limiting level of protein and caloric intake, which was as good as or better than that observed at 0.75 g/kg of protein and 100 kcal/kg. That this was not a nonspecific effect of supplementation with nonessential nitrogen was demonstrated by the fact that neither glycine nor glutamate could effectively substitute for alanine. It is important to emphasize that these infants were growing on these very low protein intakes on which growth in weight was demonstrated. They have been maintained on such regimens over long periods of time in which other measures of growth such as increase in length and head size have occurred. Both patients are approaching the age of 4 yr at the time of this report; both are still receiving very low intakes of protein and are continuing to grow and develop. Snyderman et al. (30) classically demonstrated that nonessential nitrogen could be limiting in studies of four infants on restricted protein intakes. They had initially found that there was a discrepancy between the calculated requirements for essential amino acids and actual intake required to maintain positive nitrogen balance in adults and postulated that additional nitrogen was required. In adults receiving dietary protein from cow's milk an intake of 0.5 g/kg/day was required to maintain nitrogen balance, while data from Rose and Dekker (25), indicated that using amino acids 0.2 g/kg/day should have been requin d. They then studied four infants in whom cow's milk protein was supplemented with urea or glycine. It is important to recognize that the design of their experiments was different from that of our studies. Using isocaloric diets based on cow's milk as the source of protein, protein intake was reduced to a point at which gain was reduced. Supplementation with glycine or urea restored growth in weight. Stable isotopic studies using N-15 urea demonstrated incorporation of the additional nitrogen into protein.
This nitrogen requirement from other than essential amino acids has been called "unessential" or "nonessential" nitrogen. Picou and Phillips (23), in studies of children recovering from malnutrition, have also shown the incorporation of N-15 labeled urea into protein. The amount of incorporation into protein was proportional to the degree of deprivation.
The four infants studied by Snyderman et al. (30) were 3 wk to 5 months of age. The protein intakes at which the rate of growth fell off ranged from 1.32-1.1 g/kg/day. It was of interest that when intake of protein was reduced further to the point at which growth in weight ceased, supplemental nonessential nitrogen could not restore growth. These were the conditions in our experiments in which alanine was effective but glycine was not.
At the low levels of protein intake studied, the effect of any essential nitrogen would be significant. Both patients demonstrated an improved nitrogen retention at all caloric levels when supplemental alanine was provided. The levels of nitrogen retention in the studies were low, and the differences observed may not exceed the limits of error of the method. Nevertheless, in each somparison made the retention of nitrogen was greater in the presence of alanine. The most critical comparison indicated that this retention was not simply the provision of nonessential nitrogen. This was tested by the provision of supplemental glycine and glutamic acid and neither improved nitrogen retention.
Alanine was chosen for these studies because of its key role in energy metabolism and in that of the branched-chain amino acids, which are the precursors of the intermediates of propionate metabolism that accumulate and are considered to cause clinical illness in propionic acidemia and methylmalonic acidemia. In studies of arteriovenous differences, alanine is released from muscle in amounts disproportionate to those of other amino acids or its concentration in muscle (6, 19, 28). It is synthesized by conversion of pyruvate to alanine in muscle. In this alanineglucose cycle (Fig. l) , alanine formed in muscle is transported to the liver where it serves as the predominant precursor for hepatic gluconeogenesis (6, 19, 24) . In liver, alanine is readily converted to pyruvate and then to glucose and glycogen (6, 24, 28). In muscle, alanine is formed by the transamination of glutamate and pyruvate. Glutamate in turn is formed from a-ketoglutarate by transamination. The branched-chain amino acids serve as a preferential source of nitrogen for the synthesis of alanine from pyruvate (18, 19). These amino acids are preferentially catabolized in muscle (19). This catabolism generates amino groups which cannot be converted to urea in muscle as they are in liver and are converted to alanine by transamination of pyruvate (1 3). Branched-chain amino acid transferase and alanine amino acid transferase are in close proximity intracellularly (4) and are reciprocally regulated (28) . Furthermore, leucine has recently would also be generous for the very hypotonic infants we studied. been shown to serve as a major source of the nitrogen of All patients with propionic acidemia and methylmalonic acidecirculating alanine in vivo (1) . We reasoned that the provision of mia are very hypotonic in infancy. It may very well be that this exogenous alanine might serve to spare the peripheral catabolism hypotonia and diminished muscular activity reduce their requireof essential brached-chain amino acids in an otherwise limiting ments for both energy and protein. Kerr et al. (15) have also situation, and make them available for anabolism. If a major reported decreased protein catabolism at reduced levels of intake function of the catabolism of leucine and the other branched-in malnourished infants. Our infants were on adequate caloric chain amino acids in muscle is to provide a source of alanine for intakes and had no evidence of malnutrition. The recommended gluconeogenesis, it seemed reasonable that if a plentiful source requirements for protein and nitrogen in infants 0-6 months old of alanine were provided in the diet, that this catabolic pathway based on studies of normal growth are 2.4-1.4 g/kg/day of might be susceptible to regulation and decrease. Since the source protein, (0.38-0.22 g N/kg) with recommended nitrogen retenof this catabolic pathway is whole muscle protein, sparing its tions of 180-47 mg/kg/day (7, 9), and in infants 6 months to catabolism would also potentially diminish the provision of 3 yr based on factorial analysis the recommendations are for isoleucine, threonine, methionine, and valine, and hence dimin-1.25-0.86 g/kg/day of protein (0.22-0.13 g N/kg/day) with ish the production of propionate and its products.
nitrogen retentions of 9 1-70 mg/kg/day (6). These values assume A caloric effect was also evident in these studies. At intakes of an intake of protein of high biologic value, but with considerable 100 kcallkg in the absence of alanine, adequate growth in weight additional nitrogen from other sources in ad libitum diets, and, was observed at protein intakes of 0.58 g/kg in E.A. and 0.6 g/ as such, do not represent minimum requirements for protein. kg in C.H., while at 80 kcallkg in E.A. there was no growth at 0.67 g/kg. A similar protein-sparing effect when calories weretissue. It has been shown that in most mammals, including man, the umbilical circulation is the only important route by which the fetal body acquires substrates from the maternal environment (2).
Although the umbilical uptake of substrates by the fetus can be measured by the application of the Fick principle (in which umbilical blood flow and venous arterial concentration differences are determined simultaneously), to date, however, accurate measurement of the fetal uptake of the individual AA has been made in only one species, the fetal lamb, and then only late in gestation (8, 9).
No human data are available on uptake of AA and information on the circulating concentrations of AA during early gestation is scarce (3, 10, 12). Moreover, the usefulness of the available data is limited because of the circumstances of blood collection. Thus, earlier studies were performed on fetuses at hysterotomy after placental separation and under maternal anaesthesia (3, 12), while only one fetal vessel was sampled in a more recent study in which blood samples were obtained by fetoscopy (10).
In order to overcome these difficulties we have taken advantage of the opportunity to collect simultaneous maternal and fetal artery and vein blood samples during fetoscopy without significant uterine or fetal manipulation. Herein we report results of measurement of plasma AA concentrations. Circulating concentrations of other metabolites, metabolic fuels, and hormones have also been measured and will be reported separately (1).
PATIENTS AND METHODS
Ten mothers at 18-21 wk gestation (mean 19 wk) were subjected to fetoscopy and fetal blood sampling immediately before termination of pregnancy for social reasons, within the terms of the 1967 Abortion Act; abortion was induced with intraamniotic instillation of prostaglandin immediately following the fetoscopic procedures. The study was approved by the hospital ethics committee and informed consent was obtained from the mothers.
